In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...
Kepler Capital analyst David Evans maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) on October 30 and set a price ...
GlaxoSmithKline (GSK ... controller of Germany’s Stada and owner of UK consumer products maker Thornton & Ross. Stada already announced earlier this month it would buy a small portfolio of ...
The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
Phenylephrine:CVS pulls cold medicines with the ingredient Companies such as Procter & Gamble and GSK were among several accused ... or remove such drugs from the market. The Consumer Healthcare ...
LEMSIP and other popular cold and flu tablets should be pulled from Britain’s shelves because they don’t work, experts have ...
The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an ...
The Oral Hygiene market presents a robust growth outlook with evolving consumer preferences ... Unilever, and GlaxoSmithKline ...
The Nigerian economy has seen the closure of many companies, especially multinational firms, which threw many Nigerians into ...
He said that the growth prospects for consumer products are poor because of competition from store-brand generics, and online retailers like Amazon. What GSK does next will be a test of its new ...